Cargando…

P1510: VAMIFEPORT PREVENTED THE FORMATION OF NON-TRANSFERRIN-BOUND IRON IN A MOUSE MODEL OF ΒETA-THALASSEMIA WITH BLOOD TRANSFUSIONS

Detalles Bibliográficos
Autores principales:	Kalleda, N., Flace, A., Altermatt, P., Ingoglia, G., Doucerain, C., Nyffenegger, N., Dürrenberger, F., Manolova, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429111/ http://dx.doi.org/10.1097/01.HS9.0000848896.47474.26

Ejemplares similares

Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of b-thalassemia with blood transfusions
por: Kalleda, Natarajaswamy, et al.
Publicado: (2023)

The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease
por: Nyffenegger, Naja, et al.
Publicado: (2022)

The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia
por: Nyffenegger, Naja, et al.
Publicado: (2021)

Structures of ferroportin in complex with its specific inhibitor vamifeport
por: Lehmann, Elena Farah, et al.
Publicado: (2023)

The (Bio)Chemistry of Non-Transferrin-Bound Iron
por: Silva, André M. N., et al.
Publicado: (2022)

S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
por: Locatelli, Franco, et al.
Publicado: (2023)

Cryogenics: 15.10.Solenoid
Publicado: (2004)

Cryogenics: 15.10.Solenoid
Publicado: (2005)

Cryogenics: 15.10.Solenoid
Publicado: (2005)

Sandro Botticelli 1444/45-1510
por: Deimling, Barbara
Publicado: (1994)

Dr John Caius, 1510-1573
por: Cooke, A. M.
Publicado: (1973)

Rapid endocytosis of the transferrin receptor in the absence of bound transferrin
Publicado: (1985)

Many-Body Study of Iron(III)-Bound Human Serum Transferrin
por: Lee, Hovan, et al.
Publicado: (2022)

Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion‐independent a murine model of transfusion‐dependent β‐thalassemia
por: Di Modica, Simona Maria, et al.
Publicado: (2022)

Determination of Non-Transferrin Bound Iron, Transferrin Bound Iron, Drug Bound Iron and Total Iron in Serum in a Rats after IV Administration of Sodium Ferric Gluconate Complex by Simple Ultrafiltration Inductively Coupled Plasma Mass Spectrometric Detection
por: Matta, Murali K., et al.
Publicado: (2018)

P1741: EXAMINING THE BURDEN OF ILLNESS ASSOCIATED WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA FROM THE PATIENT’S PERSPECTIVE
por: Knoth, R. L., et al.
Publicado: (2022)

Correlation of Transferrin Saturation and Serum Ferritin with Bone Mass Density in Adult Transfusion Dependent Beta-Thalassemia Patients
por: Atmakusuma, Tubagus Djumhana, et al.
Publicado: (2021)

Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron
por: Vinchi, Francesca
Publicado: (2021)

Classical and intermediate monocytes scavenge non-transferrin-bound iron and damaged erythrocytes
por: Haschka, David, et al.
Publicado: (2019)

P1558: EARLY-START DEFERIPRONE IN INFANTS/YOUNG CHILDREN WITH TRANSFUSION-DEPENDENT BETA THALASSEMIA: EVIDENCE FOR IRON SHUTTLING TO TRANSFERRIN—RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (START)
por: Tricta, F., et al.
Publicado: (2022)

Ambroise Pare and His Times, 1510—1590
Publicado: (1898)

1510. Improving the Management of Pediatric Complicated Pneumonia
por: Nuibe, Andrew M, et al.
Publicado: (2019)

Treating iron overload in patients with non-transfusion-dependent thalassemia
por: Taher, Ali T, et al.
Publicado: (2013)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

PB2238: ΒETA-THALASSEMIA INTERMEDIA: INTERACTION OF ΑLPHA-GLOBIN GENE TRIPLICATION WITH ΒETA-THALASSEMIA HETEROZYGOUS IN SPAIN
por: Ropero, P., et al.
Publicado: (2022)

Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways
por: Garbowski, Maciej W., et al.
Publicado: (2020)

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions
por: Saliba, Antoine N, et al.
Publicado: (2015)

Neoplastic transformation of rat liver epithelial cells is enhanced by non-transferrin-bound iron
por: Messner, Donald J, et al.
Publicado: (2008)

Quantitative label-free imaging of iron-bound transferrin in breast cancer cells and tumors
por: Khoo, Ting Chean, et al.
Publicado: (2020)

El Departamento Oriental, 1510-1868 : dos temas de historia económica
por: Portuondo Zúñiga, Olga
Publicado: (2012)

Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation
por: Motta, Irene, et al.
Publicado: (2020)

Pituitary iron and factors predictive of fertility status in transfusion-dependent thalassemia
por: Singer, Sylvia T., et al.
Publicado: (2020)

Iron overload status in patients with non-transfusion-dependent thalassemia in China
por: Huang, Yumei, et al.
Publicado: (2022)

P1563: INTRACELLULAR IRON OVERLOAD IMPAIRS HSC FUNCTION BY AFFECTING MITOCHONDRIAL FITNESS IN ΒETA-THALASSEMIA
por: Sighinolfi, S., et al.
Publicado: (2022)

Higher-order corrections to the large-$N_c$ bound on $M_{\eta}/M_{\eta'}$
por: Peris, S
Publicado: (1994)

Higher-Order Corrections to the Large-$N_c$ Bound on $M_{\eta}/M_{\eta'}$
por: Peris, S.
Publicado: (1994)

Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis
por: Huang, Yumei, et al.
Publicado: (2019)

Barriers to adherence to iron chelation therapy among adolescent with transfusion dependent thalassemia
por: Mohamed, Rafaa, et al.
Publicado: (2022)

Pulmonary function in patients with transfusion-dependent thalassemia and its associations with iron overload
por: Chan, Kate C., et al.
Publicado: (2023)

Los origenes de la cultura cubana (1510-1790)
por: López Segrera, Francisco, 1940-
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_1297k2k5f0ut421qfu21rvq8q6